Track topics on Twitter Track topics that are important to you
SMART drives highest quality data and compliance by unleashing data transparency, synchronous communication
PRINCETON, N.J. (PRWEB) June 25, 2018
Bioclinica®, a global life sciences services provider that utilizes science and technology to bring clarity to clinical trials, today introduces its expanded and enhanced SMART technology suite available with Medical Imaging, Electronic Data Capture (EDC) and Interactive Response Technology (IRT) combined. Bioclinica’s proven, synchronous clinical trial technologies converge all essential activities in a common data set. Investigative sites can now access Medical Imaging, EDC and IRT data via a single, easy-to-use portal where they can view, analyze and act on the data. Implementation is underway by a major pharmaceutical company and a leading CRO who are using Bioclinica’s enhanced SMART technology for their global trial portfolio.
“Our clients are already using our best-in-class SMART technology suite to Submit, Manage, Analyze, Report and Transfer medical image data compliant with global data privacy and regulatory requirements. With these new enhancements, we’re providing sponsors and CROs a catalyst to effectively and efficiently consume data throughout the trial,” says Bioclinica President & CEO David Herron. “By allowing sites to see these critical activities together, SMART eliminates cumbersome reconciliation steps and rework, creating tangible value in efficiency, quality and compliance along the data chain of custody.”
“Data transparency with real-time data reconciliation capability from start to finish is a real game-changer for our clients and their trials,” says Bioclinica’s Chief Information Officer Gavin Nichols. “SMART erases boundaries that separate processes and information.”
Additional benefits of the enhanced SMART technology suite include:
SMART allows plug-in functionality with Bioclinica Site & Patient Payments, Cardiac Safety (ECG and ABPM), and Clinical Event Adjudication, as well as third-party providers.
SMART was developed through collaboration among Bioclinica technology developers and in-house medical experts with input from industry-leading life sciences companies. “The result is clinical trial technology with the flexibility to adapt to clients' needs regardless of the size or complexity of the study protocol,” Herron explains. “Our end goal is enabling sponsors and CRO partners with better management and execution of more highly complex clinical trials on a global scale.”
Earlier this year, Clinical Informatics News recognized Bioclinica SMART with a Best Practices Award for Innovation in http://www.bioclinica.com/news-events/news-releases/bioclinica-wins-clinical-informatics-news-best-practices-award [Patient Data Management.
Bioclinica will preview SMART at the DIA Annual Global Meeting in Boston on June 25-27 where the company is exhibiting and presenting. Anyone interested is invited to schedule a one-on-one meeting during DIA or another time.
Bioclinica is a global life science provider that utilizes science and technology to bring clarity to clinical trials – helping companies to develop new life-improving therapies more efficiently and safely. Successful clinical trials require the ability to see key details and uncover hidden insights, and Bioclinica’s hundreds of experienced scientific, medical, and domain experts bring unmatched insight across the development lifecycle, from the initial protocol to post-approval. The company’s cloud-based offerings include medical imaging and cardiac safety services; clinical adjudication; randomization & trial supply management and optimization; electronic and eSource data capture; site & patient payments and budget forecasting; pharmacovigilance; trial management; and risk-based monitoring solutions. A true multifaceted partner to trial sponsors and Contract Research Organizations (CROs), Bioclinica offers a global network of research sites and patient recruitment services to provide committed, detail-focused service through all stages of drug development. The company’s thousands of employees serve more than 400 pharmaceutical, biotechnology and device organizations – including all the top 20 biopharmaceutical companies and leading CROs – through a network of offices in the U.S., Europe, and Asia.
For the original version on PRWeb visit: https://www.prweb.com/releases/2018/06/prweb15584476.htmNEXT ARTICLE
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...